Correction to: Scientific Reports https://doi.org/10.1038/s41598-017-17913-x, published online 08 January 2018
In this Article, the authors neglected to include some potential conflicts of interest. The Competing Interests section should read:
“In accordance with NHMRC policy and our ethical obligations as researchers, we report that the University of Canberra, Rao, McCuaig, Tan and Zafar have a financial interest in EpiAxis Therapeutics Pty Ltd and Forwood receive funding from EpiAxis Therapeutics Pty Ltd. Rao is also Chief Scientific Officer of EpiAxis Therapeutics Pty Ltd. We also have in place a plan for managing any potential conflicts arising from that involvement.”
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Boulding, T., McCuaig, R.D., Tan, A. et al. Author Correction: LSD1 activation promotes inducible EMT programs and modulates the tumour microenvironment in breast cancer. Sci Rep 9, 18771 (2019). https://doi.org/10.1038/s41598-019-55020-1
Published:
DOI: https://doi.org/10.1038/s41598-019-55020-1
- Springer Nature Limited
This article is cited by
-
Histone demethylases in the regulation of immunity and inflammation
Cell Death Discovery (2023)